Android app Apple app link

Legend Biotech Corporation (LEGN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$18.73
Day's range
$19.65

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/27/2026 Raymond James Sean McCutcheon $58.00 $18.87   207.38%
07/07/2026 RBC Capital Leonid Timashev $63.00 $28.04   124.68%
06/03/2026 UBS Ashwani Verma $49.00 $36.28   35.06%
05/13/2026 RBC Capital Leonid Timashev $64.00 $28.64   123.46%
05/13/2026 Morgan Stanley Terence Flynn $48.00 $27.56   74.2%
03/10/2026 Truist Financial Asthika Goonewardene $70.00 $19.56   257.87%
03/10/2026 Jefferies Cui Cui $69.00 $19.56   252.76%
02/12/2026 Redburn Partners Qize Ding $24.00 $18.54   29.45%
12/08/2025 RBC Capital Leonid Timashev $74.00 $24.56   201.3%
12/08/2025 UBS Ashwani Verma $48.00 $28.13   70.64%
07/02/2025 UBS Ashwani Verma $54.00 $35.91   50.38%
03/12/2025 H.C. Wainwright Mitchell Kapoor $75.00 $37.19   101.67%
11/13/2024 Cantor Fitzgerald Rick Bienkowski $83.00 $55.90   48.48%
10/15/2024 BTIG Justin Zelin $91.00 $44.91   102.63%
10/15/2024 Johnson Rice Gena Wang $94.00 $45.25   107.76%
10/15/2024 Barclays Gena Wang $94.00 $44.91   109.31%
10/08/2024 Redburn Partners Qize Ding $86.00 $49.58   73.46%
06/17/2024 Piper Sandler Edward Tenthoff $90.00 $42.00   114.29%
06/17/2024 Truist Financial Asthika Goonewardene $88.00 $42.45   107.3%
05/23/2024 Deutsche Bank James Shin $60.00 $40.04   49.85%
05/17/2024 Morgan Stanley Matthew Harrison $82.00 $46.37   76.84%
05/14/2024 RBC Capital Leonid Timashev $86.00 $42.97   100.14%
04/17/2024 Scotiabank George Farmer $65.00 $50.12   29.69%
04/03/2024 Cantor Fitzgerald Rick Bienkowski $82.00 $56.43   45.31%
03/14/2024 BMO Capital Kostas Biliouris $90.00 $66.11   36.14%

Legend Biotech Corp FAQ's

Legend Biotech Corp has been rated by research analysts at Morgan Stanley, Oppenheimer, Barclays, Raymond James, RBC Capital, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.